We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$30M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.2M
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$10.6M
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$7.95M
5
IBM icon
IBM
IBM
+$5.84M

Top Sells

Rank Stock Value
1
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
+$10.2M
2
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$8.32M
3
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$7.79M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$5.38M
5
KMB icon
Kimberly-Clark
KMB
+$5.23M

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTP
1551
DELISTED
Nam Tai Property Inc.
NTP
– –
-26,000
Closed -$186K
QIWI
1552
DELISTED
QIWI PLC
QIWI
– –
-4,481
Closed -$251K
CHL
1553
DELISTED
China Mobile Limited
CHL
– –
-3,872
Closed -$202K
SOIL
1554
DELISTED
Global X Fertilizers/Potash ETF
SOIL
– –
-15,152
Closed -$173K
OREX
1555
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-9,420
Closed -$530K
PNY
1556
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
– –
-7,677
Closed -$255K
NQS
1557
DELISTED
NUVEEN SELECT QUALITY MUNI FD
NQS
– –
-10,074
Closed -$125K
HYF
1558
DELISTED
MANAGED HIGH YLD PLUS FD INC
HYF
– –
-18,655
Closed -$38K
WRES
1559
DELISTED
WARREN RESOURCES INC
WRES
– –
-65,000
Closed -$204K
PWJ
1560
DELISTED
POWERSHARES DYNAMIC MID CAP GRTH PORTFOLIO
PWJ
– –
-7,054
Closed -$205K
HK
1561
DELISTED
Halcon Resources Corporation
HK
– –
-349
Closed -$232K
OXGN
1562
DELISTED
OXIGENE INC COM
OXGN
– –
-50,000
Closed -$126K
59 60 61 62
63

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.